GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » PB Ratio

EirGenix (ROCO:6589) PB Ratio : 2.45 (As of May. 24, 2024)


View and export this data going back to 2016. Start your Free Trial

What is EirGenix PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-24), EirGenix's share price is NT$79.60. EirGenix's Book Value per Share for the quarter that ended in Mar. 2024 was NT$32.47. Hence, EirGenix's PB Ratio of today is 2.45.

Good Sign:

EirGenix Inc stock PB Ratio (=2.54) is close to 1-year low of 2.37

The historical rank and industry rank for EirGenix's PB Ratio or its related term are showing as below:

ROCO:6589' s PB Ratio Range Over the Past 10 Years
Min: 2.01   Med: 2.99   Max: 22.89
Current: 2.48

During the past 11 years, EirGenix's highest PB Ratio was 22.89. The lowest was 2.01. And the median was 2.99.

ROCO:6589's PB Ratio is ranked better than
50.38% of 1314 companies
in the Biotechnology industry
Industry Median: 2.51 vs ROCO:6589: 2.48

During the past 12 months, EirGenix's average Book Value Per Share Growth Rate was -5.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 55.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 32.00% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 12.70% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of EirGenix was 55.00% per year. The lowest was -9.50% per year. And the median was 9.95% per year.

Back to Basics: PB Ratio


EirGenix PB Ratio Historical Data

The historical data trend for EirGenix's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EirGenix PB Ratio Chart

EirGenix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.51 5.09 3.21 3.50 3.07

EirGenix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.38 3.29 2.89 3.07 2.68

Competitive Comparison of EirGenix's PB Ratio

For the Biotechnology subindustry, EirGenix's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EirGenix's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EirGenix's PB Ratio distribution charts can be found below:

* The bar in red indicates where EirGenix's PB Ratio falls into.



EirGenix PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

EirGenix's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=79.60/32.471
=2.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


EirGenix  (ROCO:6589) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


EirGenix PB Ratio Related Terms

Thank you for viewing the detailed overview of EirGenix's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EirGenix (ROCO:6589) Business Description

Traded in Other Exchanges
N/A
Address
No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in biosimilar and new drug research and development as well as biopharmaceutical contract development and manufacturing services, including cell line construction platforms, process development platforms, analytical science and protein characterisation, as well as PIC/S facilities to provide clinical trial drug production. Its services include Cell Line Development, Process Development, Analytical Science and Quality Control, cGMP manufacturing-mammalian system, cGMP manufacturing-microbial system, and Antibody Drug Conjugate.

EirGenix (ROCO:6589) Headlines

No Headlines